Tags: freezing | ovarian | cancer | tumors | cryoablation

Freezing Ovarian Tumors Saves Lives

Thursday, 09 February 2012 02:59 PM

Freezing ovarian tumors can extend the lives of women with cancer that has spread to other parts of the body and is cost-effective, according to new research.
The study, presented at the annual Symposium on Clinical Interventional Oncology in Miami, involved 21 ovarian cancer patients with tumors that had spread to the abdomen, liver, lung and bone, and could not be removed surgically.
Cryoablation – a freezing technique -- was used to treat 48 tumors, killing 47 of them (98 percent). The average patient survival time was more than four years and seven months – compared typical survival of about seven months to 2 1/2 years in women with advanced metastatic cancer, researchers said.
On average, more than three years had transpired from the time of diagnosis to the first cryoablation treatment.
The study also determined the treatment was extremely cost-effective, costing an average of $26,806 per life year saved, well below the current standard of $100,000.
"This study adds to the evidence that cryoablation is an effective option for patients who can't have surgery," said study author Dr. Hyun J. Bang, of Wayne State University/Detroit Medical Center. "This procedure is often overlooked, but based on the high survival rate, cost effectiveness, consistent local control and safety of the procedure, we should be taking a closer look at cryoablation."

© HealthDay

1Like our page
A new tumor-freezing technique adds years to the lives of ovarian cancer patients, researchers report.
Thursday, 09 February 2012 02:59 PM
Newsmax Media, Inc.

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

© Newsmax Media, Inc.
All Rights Reserved